References

  1. World Health Organization. Treat 3 Million by 2005 Initiative. Treating 3 million by 2005: making it happen: the WHO strategy: the WHO and UNAIDS global initiative to provide antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005. 2003. Geneva. World Health Organization. Google Scholar

  2. Ministry of Health. Towards universal access to antiretroviral therapy: Ghana national ART scale up plan: 2006 -2010. 2006. Accra. Ministry of Health/Ghana Health Service.

  3. National AIDS/STI Control Programme. 2010 Annual Report. 2011. Accra, Ghana. National AIDS/STI Control Programme.

  4. World Health Organization. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. 2011. Geneva. World Health Organization. Google Scholar

  5. Lowrance David, Ndamage Francois, Kayirangwa Eugenie, Ndagije Felix, et al. Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-200 J Acquir Immune Defic Syndr. 2009; 52(1):49-55. PubMed | Google Scholar

  6. Bussmann Hermann, Wester William, Ndwapi Ndwapi, Grundmann Nicolas, et al. Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program. AIDS. 2008; 22(17):2303-11. PubMed | Google Scholar

  7. Lahuerta Maria, Lima Josue, Elul Batya, Okamura Mie, et al. Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes. J Acquir Immune Defic Syndr. 2011; 58(3): e75-e86. PubMed | Google Scholar

  8. Nglazi Mweete, Kranzer Katharina, Holele Pearl, Kaplan Richard, et all. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infectious Diseases. 2012; 12:21. PubMed | Google Scholar

  9. Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS. 2006; 20(8):1181-1189. PubMed | Google Scholar

  10. Stringer JS, Zulu I, Levy J, Stringer EM, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006; 296(7):782-793. PubMed | Google Scholar

  11. Howley IW, Lartey M, Machan JT, Talbot EA, et al. Highly active antiretroviral therapy and employment status in Accra, Ghana. Ghana Med J. 2010; 44 (4): 144-149. PubMed | Google Scholar

  12. Collini Paul, Schwab Uli, Sarfo Stephen, Obeng-Baah Joseph, et al. Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort. Clin Infect Dis. 2009; 48(7):988-91. PubMed | Google Scholar

  13. Ohene S, Forson E. Care of patients on anti-retroviral therapy in Kumasi Metropolis. Ghana Med J. 2009; 43(4):144-149. PubMed | Google Scholar

  14. National AIDS/STI Control Programme. Guidelines for Anti Retro-viral Therapy in Ghana. 2005. Accra, Ghana. National HIV/ AIDS/ STI Control Programme, Ministry of Health/ Ghana Health Service.

  15. Rosen S, Ketlhapile M, Sanne I, Desilva MB. Characteristics of patients accessing care and treatment for HIV/AIS at public and nongovernmental sites in South Africa. J Int Assoc Physicians AIDS Care. 2008; 7(4):200-7. PubMed | Google Scholar

  16. Dako-Gyeke Phyllis, Snow Rachel, Yawson Alfred. Who is utilizing anti-retroviral therapy in Ghana: an analysis of ART service utilization. Int J Equity Health. 2012; 11:62. PubMed | Google Scholar

  17. World Health Organization. Priority intervention: HIV/AIDS prevention, treatment and care in the health sector. 2010. Geneva. Version 2.0 World Health Organization. Google Scholar

  18. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. 2011. Geneva. World Health Organization. PubMed | Google Scholar

  19. Boulle A, Orrel C, Kaplan R, Van Cutsem G, et al. International Epidemiological Databases to Evaluate AIDS in Southern Africa Collaboration. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antivir Ther. 2007;12(5):753-60. PubMed | Google Scholar

  20. Forna F, Liechty CA, Solberg P, Asiimwe F, et al. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr. 2007; 44(4):456-62. PubMed | Google Scholar

  21. Sivadasan A, Abraham OC, Rupali P, Pulimood SA, et al. High rates of regimen change due to drug toxicity among a cohort of South Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment. J Assoc Physicians India. 2009; 57:384-8. PubMed | Google Scholar

  22. O'Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort. J Acquir Immune Defic Syndr. 2003; 34(4):407-14. PubMed | Google Scholar

  23. Wilhelm AK, Paci G, Lartey M, Kwara A. Treatment Default among Patients Initiating HAART at the Korle-Bu Teaching Hospital in Accra, Ghana. West Afr J Med. 2012 Sep-Oct;31(4):264-9. PubMed | Google Scholar

  24. Boateng Daniel, Kwapong Golda, Agyei-Baffour Peter. Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional study. BMC Women's Health. 2013; 13:2. PubMed | Google Scholar

  25. Mills Edward, Nachega Jean, Bangsberg David, Singh Sonal, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006; 3(11): e438. PubMed | Google Scholar

  26. Zachariah R, Van Engelgem I, Massaquoi M, Kocholla L, et al. Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Trans R Soc Trop Med Hyg. 2008 Mar 102 (3):288-93. PubMed | Google Scholar

  27. Huang Laurence, Crothers Kristina. HIV-associated opportunistic pneumonias. Respirology. 2009; 14(4): 474-485. PubMed | Google Scholar

  28. Focà Emanuele, Odolini Silvia, Brianese Nigritella, Carosi Giampiero. Malaria and HIV in adults: when the parasite runs into the virus. Mediterr J Hematol Infect Dis. 2012; 4(1): e2012032. PubMed | Google Scholar

  29. Harish MR, Shanmukhappa, Kumar S, Kumar M, Gowda MS. A study of cutaneous manifestations in HIV infected persons. J Indian Med Assoc. 2012; 110(10):726-7. PubMed | Google Scholar

  30. Koethe JR, Lukusa A, Giganti MJ, Chi BH, et al. Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2009; 53(4):507-13. PubMed | Google Scholar